- RecruitingPHASE3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
This study is testing a new injection, Xeomin, for people with frequent migraines. We want to see if it reduces the number of migraine days compared to a dummy injection (placebo). It involves head and neck injections and lasts about a year.
For: Chronic MigraineUnited States · Austria · Canada - RecruitingPHASE3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
This study is testing a new injection called Xeomin to see if it can help reduce the number of migraine days for people who experience episodic migraines. We want to find out if it's safe and effective compared to a dummy injection.
For: Episodic MigraineUnited States · Austria · Canada - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A prospective, randomized, double-blind, placebo-controlled, two-stage, multicenter study with an open-label extension period to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity in children and adolescents with cerebral palsy
This study is testing a medicine called NT 201 (also known as Xeomin) for children and teenagers with cerebral palsy who have stiff leg muscles. It aims to see if the medicine helps reduce the stiffness and improve movement, compared to a dummy treatment.
For: Pediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP)Latvia · Poland